Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Placebo Controlled, Randomized, Phase II Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

NCT02724254 is registered in ClinicalTrials.gov with Vaxart as lead sponsor.

NCT NCT02724254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02724254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Placebo Controlled, Randomized, Phase II Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients
Lead sponsor
Vaxart
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
July 31, 2018
Enrollment
218 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

condyloma